Pricing Log in Create free account

CASI Pharmaceuticals Inc. (CASIF) vs Psyence Biomedical Ltd. (PBM)

CASI Pharmaceuticals Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. CASI Pharmaceuticals Inc. is the larger, with a market value of $12.4M against $11.2M — 1.1× the size. CASI Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Psyence Biomedical Ltd. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, CASI Pharmaceuticals Inc. leads on 5 and Psyence Biomedical Ltd. on 5.

Valuation

Metric CASIF PBM Biotechnology median
P/E n/m 0.13 10.26
P/S 0.09 n/m 9.18
P/B n/m 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 1.91 0.65
EV/Sales 1.79 n/m 8.98
Earnings yield (2,701.50%) 759.84% (34.89%)
Free cash flow yield (3,801.00%) (1,147.64%) (24.52%)

Profitability

Metric CASIF PBM Biotechnology median
Gross margin 48.65% — 65.16%
Operating margin (206.87%) — 0.00%
Net margin (232.03%) 0.00% 0.00%
Free cash flow margin (340.20%) 0.00% 0.00%
Return on equity 0.00% (23.52%) (50.12%)
Return on assets 0.00% (6.74%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CASIF PBM Biotechnology median
Revenue growth (TTM) (27.42%) — 6.26%
EPS growth (last fiscal year) (1.17%) (138.35%) 29.88%
Revenue growth, 5-year CAGR 6.47% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CASIF PBM Biotechnology median
Debt to equity (0.34) 0.00 0.00
Current ratio 0.15 8.09 4.89
Net debt to EBITDA (0.43) 1.20 1.01

Dividend

Metric CASIF PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CASIF PBM Biotechnology median
Market cap 12.39m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack